ArticleOncotarget2018

Co-targeting of Tiam1/Rac1 and Notch ameliorates chemoresistance against doxorubicin in a biomimetic 3D lymphoma model.

Muhammad Ikram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.